Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

279 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to Ravulizumab

NCT05972967

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Omeros Investigational Site Aachen, Germany
  • Omeros Investigational Site Ulm, Germany
  • Omeros Investigational Site Thessaloniki, Greece
  • Omeros Investigational Site Lausanne, Switzerland
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Oral HRS-5965 in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy

NCT06593938

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • The Blood Disease Hospital of the Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details
Completed

An Extension Clinical Study of BCD-148 for the Treatment of Patients With PNH Previously Treated in Clinical Study No. BCD-148-2/NOCTURN

NCT06987864

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Territorial State Budgetary Healthcare Institution "Territorial Clinical Hospital" Barnaul, Russia
  • State Autonomous Healthcare Institution "S.V. Belyaev Kuzbass Regional Clinical Hospital" Kemerovo, Russia
  • Federal State Budgetary Institution of Science "Kirov Research Institute of Hematology and Blood Transfusion of the Federal Medical and Biological Agency" Kirov, Russia
  • Moscow State Budgetary Healthcare Institution "S.P. Botkin Municipal Clinical Hospital of the Moscow Healthcare Department" Moscow, Russia
View Trial Details
Completed

Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT02534909

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Novartis Investigative Site Brno-Bohunice, Czech Republic, Czechia
  • Novartis Investigative Site Fukushima, Japan
  • Novartis Investigative Site Isehara, Kanagawa, Japan
  • Novartis Investigative Site Suita, Osaka, Japan
View Trial Details
Completed

Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)(ALPHA)

NCT04469465

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +8 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Weston, Florida, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Kalamazoo, Michigan, United States
View all 62 locations
View Trial Details

Related conditions